Early data shows 24% weight loss over 48 weeks, substantially exceeding semaglutide results
Many of the extrinsic factors that impact oligodendrocyte function [e.g., pro-inflammatory cytokines, reactive oxygen species (ROS)] are the products of other glial cells and will be discussed in more detail subsequently
With TRIUMPH-4 (December 2025, 28.7% weight loss), TRIUMPH-1 (May 2026, 28.3% in 2,339 patients), and now TRANSCEND-T2D-1 (June 2026, the first diabetes-specific Phase 3 readout) all confirmed, this investigational medication is rapidly approaching regulatory review
There is no known direct interaction between losartan and vitamin D supplements
The initial reaction rates at different concentrations of compound were used to determine EC 50 values, which were calculated with a four-parameter logistical model of log dose against percentage activation and were obtained from at least three sets of experiments